Nuclear factor kappa B (NF-kappa B), nuclear factor interleukin-6 (NFIL-6 or C/EBP beta) and nuclear factor interleukin-6 beta (NFIL6-beta or C/EBP delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line. [electronic resource]
Producer: 19961024Description: 624-31 p. digitalISSN:- 0014-2956
- Base Sequence
- Breast Neoplasms -- genetics
- CCAAT-Enhancer-Binding Protein-delta
- CCAAT-Enhancer-Binding Proteins
- Carcinoma -- genetics
- Cycloheximide -- pharmacology
- Cytokines -- pharmacology
- DNA-Binding Proteins -- metabolism
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Interleukin-6 -- genetics
- Molecular Sequence Data
- NF-kappa B -- metabolism
- Nuclear Proteins -- metabolism
- Promoter Regions, Genetic
- RNA, Messenger -- biosynthesis
- RNA, Neoplasm -- biosynthesis
- Transcription Factors -- metabolism
- Transcription, Genetic
- Transcriptional Activation
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.